NEW YORK, Aug. 30 – Galapagos Genomics and the Flanders Interuniversity Institute for Biotechnology have entered a collaboration to identify and validate Alzheimer-related gene targets, the companies announced Thursday.

Under the terms of the collaboration, Galapagos, a privately held company based in Belgium, integrate its PhenoSelect gene function discovery platform with the Flanders Interuniversity Institute for Biotechnology’s (VIB) cell-based presesilin-gamma-secretase assays to screen its human gene library for genes involved in Alzheimer’s Disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.